Corcept Therapeutics Market Sentiment

Corcept Therapeutics Inc

CORTNASDAQ

Trade with Public

$122.25

1.200.99%

À la clôture: Aug 21, 5:00 PM EST

$122.25

N/A

Après les heures: Aug 21, 4:00 PM EST

Aperçu Actualités Prévisions de résultats Événements Objectifs de cours Données financièresSentimentActionnariat Comparer Options Rapport sur les stocks

Corcept Therapeutics Market Sentiment

Market sentiment signals for Corcept Therapeutics (CORT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 11.7% short float

Options Flow▲ 0.87 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

6 analysts

Options Flow (P/C)

0.87

More calls — Bullish

1,013 calls · 884 puts

Avg Consensus PT

$127

+4.0%

Highest Price Target

$165

+35.0%

Piper Sandler

Lowest Price Target

$50

-59.1%

Wolfe Research

Short Interest

11.7%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Jul 30, 2026	Piper Sandler	David Amsellem—	+35.0%	$88 → $165	Maintained	Overweight
Jul 30, 2026	Canaccord Genuity	Edward Nash—	+31.7%	$150 → $161	Maintained	Buy
Jul 30, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	+35.0%	$95 → $165	Maintained	Buy
Jul 29, 2026	Canaccord Genuity	Edward Nash—	+22.7%	$135 → $150	Maintained	Buy
Jul 27, 2026	Wolfe Research	Kalpit Patel—	-59.1%	$50	Downgrade	Peer Perform→Underperform
May 28, 2026	Canaccord Genuity	Edward Nash—	+10.4%	$110 → $135	Maintained	Buy
May 28, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-22.3%	$75 → $95	Maintained	Buy
May 13, 2026	UBS	Ashwani Verma—	-41.1%	$44 → $72	Upgrade	Neutral→Buy
May 4, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-38.7%	$60 → $75	Maintained	Buy
May 1, 2026	Piper Sandler	David Amsellem—	-28.0%	$73 → $88	Maintained	Overweight
Mar 26, 2026	Canaccord Genuity	Edward Nash—	-10.0%	$100 → $110	Maintained	Buy
Mar 26, 2026	Wolfe Research	Kalpit Patel—	—	—	Upgrade	Underperform→Peer Perform
Mar 25, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-50.9%	$67 → $60	Maintained	Buy
Feb 25, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-50.9%	$67 → $60	Maintained	Buy
Feb 20, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-45.2%	$105 → $67	Maintained	Buy
Jan 23, 2026	Canaccord Genuity	Edward Nash—	-18.2%	$99 → $100	Maintained	Buy
Jan 23, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-14.1%	$90 → $105	Maintained	Buy
Jan 2, 2026	Canaccord Genuity	Edward Nash—	-19.0%	$140 → $99	Maintained	Buy
Jan 2, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-26.4%	$145 → $90	Maintained	Buy
Dec 16, 2025	UBS	Ashwani Verma—	-22.3%	$95	Initiate	Neutral
Nov 25, 2025	HC Wainwright & Co.	Swayampakula Ramakanth—	+18.6%	$145 → $145	Maintained	Buy
Nov 18, 2025	Wolfe Research	Kalpit Patel—	—	—	Initiate	Peer Perform
Oct 20, 2025	HC Wainwright & Co.	Swayampakula Ramakanth—	+18.6%	$145 → $145	Maintained	Buy
Oct 10, 2025	HC Wainwright & Co.	Swayampakula Ramakanth—	+18.6%	$145 → $145	Maintained	Buy
Sep 25, 2025	Canaccord Genuity	Edward Nash—	+14.5%	$140 → $140	Maintained	Buy